Log in
Enquire now
‌

US Patent 11129882 Virus like particle with efficient epitope display

Patent 11129882 was granted and assigned to University of Copenhagen on September, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
University of Copenhagen
University of Copenhagen
0
Current Assignee
University of Copenhagen
University of Copenhagen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111298820
Patent Inventor Names
Thor Theander0
Morten Agertoug Nielsen0
Susan Thrane0
Adam Frederik Sander Bertelsen0
Ali Salanti0
Christoph Mikkel Janitzek0
Mette Ørskov0
Date of Patent
September 28, 2021
0
Patent Application Number
201610280
Date Filed
October 28, 2016
0
Patent abstract

The invention relates to a virus like particle (VLP) based vaccine. The virus-like particle constitutes a non-naturally occurring, ordered and repetitive antigen array display scaffold which can obtain a strong and long-lasting immune response in a subject. The VLP based vaccine may be used for the prophylaxis and/or treatment of a disease including, but is not limited to, cancer, cardiovascular, infectious, asthma, and/or allergy diseases/disorders.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11129882 Virus like particle with efficient epitope display

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.